Marimed (MRMD) Depreciation & Amortization (CF) (2016 - 2026)
Marimed (MRMD) posted quarterly Depreciation & Amortization (CF) of $2.2 million for Q1 2026, up 19.15% year-over-year from $1.8 million in Q1 2025, and up 3.86% quarter-over-quarter from $2.1 million in Q4 2025.
Marimed (MRMD) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
Marimed (MRMD) has reported Depreciation & Amortization (CF) for 11 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 19.15% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $8.5 million (up 8.69% YoY), while the FY2025 annual figure was $8.1 million, up 2.52% from the prior year.
- Depreciation & Amortization (CF) grew to $2.2 million in Q1 2026 per MRMD's latest filing, from $2.1 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $2.2 million in Q4 2024 and bottomed at $702000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $1.6 million across 5 years, with a median of $1.8 million in 2024.
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) soared 96.55% — and 2025, when it retreated 6.76%.
- Marimed's Depreciation & Amortization (CF) stood at $963000.0 in 2022, then jumped by 77.67% to $1.7 million in 2023, then rose by 26.3% to $2.2 million in 2024, then dropped by 4.07% to $2.1 million in 2025, then rose by 3.86% to $2.2 million in 2026.
- Business Quant data shows MRMD's Depreciation & Amortization (CF) at $2.2 million in Q1 2026, $2.1 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | 2.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33 Mn |
| Jun 30, 2026 | 2.33 Mn |
| Mar 31, 2026 | 2.15 Mn |
| Mar 31, 2026 | 2.15 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Mar 31, 2024 | 1.94 Mn |